MEDICINES360

Lobbying client · California · filed 2025 to 2026

To catalyze equitable access to medicines & devices

$40,000 Reported spend

5 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page comes from one LDA client record (61609), filed by the registrant listed below.

Who filed for this client 1

G2G CONSULTING $40,000 Outside firm · 5 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $0 1 filing
2025 $40,000 4 filings

Issues lobbied 1

Health Issues 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Defense, Dept of (DOD) 5
Food & Drug Administration (FDA) 5
Health & Human Services, Dept of (HHS) 5
Natl Institutes of Health (NIH) 5

Recent filings 5 total

Q1 termination

G2G CONSULTING

1st Quarter 2026 (Jan 1 - Mar 31) · posted Apr 16, 2026

View → Q4 report

G2G CONSULTING

4th Quarter 2025 (Oct 1 - Dec 31) · $10,000 income · posted Jan 20, 2026

View → Q3 report

G2G CONSULTING

3rd Quarter 2025 (July 1 - Sep 30) · $10,000 income · posted Oct 14, 2025

View → Q2 report

G2G CONSULTING

2nd Quarter 2025 (Apr 1 - June 30) · $10,000 income · posted Jul 13, 2025

View → Q1 report

G2G CONSULTING

1st Quarter 2025 (Jan 1 - Mar 31) · $10,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.